Free Trial

CME Group Inc. (NASDAQ:CME) Shares Sold by Banque Pictet & Cie SA

CME Group logo with Finance background

Banque Pictet & Cie SA cut its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 3.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 65,043 shares of the financial services provider's stock after selling 2,082 shares during the quarter. Banque Pictet & Cie SA's holdings in CME Group were worth $17,255,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Wayfinding Financial LLC purchased a new stake in CME Group during the 1st quarter worth about $25,000. Cornerstone Planning Group LLC increased its holdings in CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after purchasing an additional 55 shares during the period. New Age Alpha Advisors LLC increased its holdings in CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the period. Golden State Wealth Management LLC lifted its position in shares of CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after purchasing an additional 98 shares during the last quarter. Finally, Alpine Bank Wealth Management purchased a new stake in shares of CME Group during the 1st quarter worth $32,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Wall Street Zen raised shares of CME Group from a "sell" rating to a "hold" rating in a research report on Saturday, July 5th. Morgan Stanley boosted their target price on CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a report on Thursday, April 24th. Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Piper Sandler boosted their target price on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 8th. Finally, JPMorgan Chase & Co. decreased their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $260.93.

Read Our Latest Stock Analysis on CME

CME Group Stock Up 0.0%

Shares of CME stock traded up $0.10 during mid-day trading on Thursday, reaching $275.74. 688,936 shares of the company's stock traded hands, compared to its average volume of 2,192,489. CME Group Inc. has a 12 month low of $193.17 and a 12 month high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market cap of $99.37 billion, a P/E ratio of 27.77, a P/E/G ratio of 3.74 and a beta of 0.44. The company's 50-day moving average price is $276.73 and its 200-day moving average price is $258.73.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The firm's quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business posted $2.50 earnings per share. On average, equities analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date was Monday, June 9th. CME Group's payout ratio is 50.30%.

Insider Buying and Selling at CME Group

In related news, insider Derek Sammann sold 4,650 shares of the firm's stock in a transaction on Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the sale, the insider owned 8,336 shares in the company, valued at approximately $2,339,164.96. This trade represents a 35.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Dennis Suskind sold 1,000 shares of CME Group stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total value of $271,280.00. Following the completion of the sale, the director owned 2,915 shares in the company, valued at approximately $790,781.20. The trade was a 25.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 13,400 shares of company stock worth $3,680,610. Insiders own 0.30% of the company's stock.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines